• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Internet Res . Prognosis score system to predict survival outcome of COVID-19: a Korean nationwide cohort study

tetano

Editor, Senior Moderator
J Med Internet Res


. 2021 Feb 3.
doi: 10.2196/26257. Online ahead of print.
Prognosis score system to predict survival outcome of COVID-19: a Korean nationwide cohort study


Sung-Yeon Cho[SUP] 1 2 [/SUP], Sung-Soo Park[SUP] 1 3 [/SUP], Min-Kyu Song[SUP] 4 5 [/SUP], Young Yi Bae[SUP] 1 [/SUP], Dong-Gun Lee[SUP] 6 2 [/SUP], Dong-Wook Kim[SUP] 1 3 [/SUP]



Affiliations

Abstract

Background: As the coronavirus disease 2019 (COVID-19) pandemic continues, initial risk-adapted allocation is crucial for managing medical resources and providing intensive care.
Objective: This study aimed to identify factors that predict COVID-19 overall survival rate and develop a COVID-19 prognosis score (COPS) based on these factors. Also, severity of patients' illness and length of hospital stay were analyzed.
Methods: This study retrospectively analyzed nationwide cohort of laboratory-confirmed COVID-19 cases between January and April 2020 in Korea. The cohort was split randomly into the development cohort and the validation cohorts with 2:1 ratio. In the development cohort (n=3,729), we tried to identify factors associated with overall survival (OS) and create a scoring system to predict OS using identified parameters by Cox proportional hazard regression model with bootstrapping methods. The prediction accuracy was evaluated in the validation cohort (n=1,865) using the area under the curve (AUC) by receiver operating characteristics curves. Each variable's score in the COPS system was rounded off following the log-scaled conversion of the adjusted hazard ratio.
Results: Among the 5,594 patients included in this analysis, 234 died after COVID-19 diagnosis. In the development cohort, six parameters were significantly related to poor overall survival: advanced age; dementia; chronic renal failure; dyspnea; mental disturbance; and absolute lymphocyte count <1,000 /mm3. Afterward, the COPS system was developed, and risk groups were created: low-risk (score, 0-2), intermediate-risk (score, 3), high-risk (score, 4), and very high-risk (score, 5-7). The COPS system yielded an AUC of .918 for predicting 14-days survival rate and .896 for predicting 28-days survival rate in the validation cohort. Using the COPS system, 28-days overall survival rates were discriminatively estimated as 99.8%, 95.4%, 82.3%, and 55.1% in low-risk, intermediate-risk, high risk, and very high-risk groups in the total cohort, respectively (P <.001). Length of hospital stay and disease severity were directly associated with the survivors (P <.001), and survivors stayed in a hospital significantly longer than non-survivors (26.1?10.7 vs. 15.6?13.3 days).
Conclusions: The newly developed predictive COPS system may assist in risk-adapted decisions for medical resources allocation, including intensive care, during the COVID-19 pandemic.
 
Back
Top Bottom